Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Neutropenia Biologic Drug Treatment market report explains the definition, types, applications, major countries, and major players of the Neutropenia Biologic Drug Treatment market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Myelo Therapeutics GmbH
Dong-A ST CO Ltd
CVS Health
Amgen
Baxter International
Enzychem Lifesciences Corporation
Kyowa Kirin
Cellerant Therapeutics
Partner Therapeutics
Pfizer
Novartis
Teva Pharmaceutical Industries Ltd
Sanofi
By Type:
Filgrastim
Pegfilgrastim
Lenograstim
Lipegfilgrastim
Sargramostim
By End-User:
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Neutropenia Biologic Drug Treatment Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Neutropenia Biologic Drug Treatment Outlook to 2028- Original Forecasts
-
2.2 Neutropenia Biologic Drug Treatment Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Neutropenia Biologic Drug Treatment Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Neutropenia Biologic Drug Treatment Market- Recent Developments
-
6.1 Neutropenia Biologic Drug Treatment Market News and Developments
-
6.2 Neutropenia Biologic Drug Treatment Market Deals Landscape
7 Neutropenia Biologic Drug Treatment Raw Materials and Cost Structure Analysis
-
7.1 Neutropenia Biologic Drug Treatment Key Raw Materials
-
7.2 Neutropenia Biologic Drug Treatment Price Trend of Key Raw Materials
-
7.3 Neutropenia Biologic Drug Treatment Key Suppliers of Raw Materials
-
7.4 Neutropenia Biologic Drug Treatment Market Concentration Rate of Raw Materials
-
7.5 Neutropenia Biologic Drug Treatment Cost Structure Analysis
-
7.5.1 Neutropenia Biologic Drug Treatment Raw Materials Analysis
-
7.5.2 Neutropenia Biologic Drug Treatment Labor Cost Analysis
-
7.5.3 Neutropenia Biologic Drug Treatment Manufacturing Expenses Analysis
8 Global Neutropenia Biologic Drug Treatment Import and Export Analysis (Top 10 Countries)
-
8.1 Global Neutropenia Biologic Drug Treatment Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Neutropenia Biologic Drug Treatment Export by Region (Top 10 Countries) (2017-2028)
9 Global Neutropenia Biologic Drug Treatment Market Outlook by Types and Applications to 2022
-
9.1 Global Neutropenia Biologic Drug Treatment Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Filgrastim Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Pegfilgrastim Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Lenograstim Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Lipegfilgrastim Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Sargramostim Consumption and Growth Rate (2017-2022)
-
9.2 Global Neutropenia Biologic Drug Treatment Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Online Pharmacies Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Neutropenia Biologic Drug Treatment Market Analysis and Outlook till 2022
-
10.1 Global Neutropenia Biologic Drug Treatment Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Neutropenia Biologic Drug Treatment Consumption (2017-2022)
-
10.2.2 Canada Neutropenia Biologic Drug Treatment Consumption (2017-2022)
-
10.2.3 Mexico Neutropenia Biologic Drug Treatment Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Neutropenia Biologic Drug Treatment Consumption (2017-2022)
-
10.3.2 UK Neutropenia Biologic Drug Treatment Consumption (2017-2022)
-
10.3.3 Spain Neutropenia Biologic Drug Treatment Consumption (2017-2022)
-
10.3.4 Belgium Neutropenia Biologic Drug Treatment Consumption (2017-2022)
-
10.3.5 France Neutropenia Biologic Drug Treatment Consumption (2017-2022)
-
10.3.6 Italy Neutropenia Biologic Drug Treatment Consumption (2017-2022)
-
10.3.7 Denmark Neutropenia Biologic Drug Treatment Consumption (2017-2022)
-
10.3.8 Finland Neutropenia Biologic Drug Treatment Consumption (2017-2022)
-
10.3.9 Norway Neutropenia Biologic Drug Treatment Consumption (2017-2022)
-
10.3.10 Sweden Neutropenia Biologic Drug Treatment Consumption (2017-2022)
-
10.3.11 Poland Neutropenia Biologic Drug Treatment Consumption (2017-2022)
-
10.3.12 Russia Neutropenia Biologic Drug Treatment Consumption (2017-2022)
-
10.3.13 Turkey Neutropenia Biologic Drug Treatment Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Neutropenia Biologic Drug Treatment Consumption (2017-2022)
-
10.4.2 Japan Neutropenia Biologic Drug Treatment Consumption (2017-2022)
-
10.4.3 India Neutropenia Biologic Drug Treatment Consumption (2017-2022)
-
10.4.4 South Korea Neutropenia Biologic Drug Treatment Consumption (2017-2022)
-
10.4.5 Pakistan Neutropenia Biologic Drug Treatment Consumption (2017-2022)
-
10.4.6 Bangladesh Neutropenia Biologic Drug Treatment Consumption (2017-2022)
-
10.4.7 Indonesia Neutropenia Biologic Drug Treatment Consumption (2017-2022)
-
10.4.8 Thailand Neutropenia Biologic Drug Treatment Consumption (2017-2022)
-
10.4.9 Singapore Neutropenia Biologic Drug Treatment Consumption (2017-2022)
-
10.4.10 Malaysia Neutropenia Biologic Drug Treatment Consumption (2017-2022)
-
10.4.11 Philippines Neutropenia Biologic Drug Treatment Consumption (2017-2022)
-
10.4.12 Vietnam Neutropenia Biologic Drug Treatment Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Neutropenia Biologic Drug Treatment Consumption (2017-2022)
-
10.5.2 Colombia Neutropenia Biologic Drug Treatment Consumption (2017-2022)
-
10.5.3 Chile Neutropenia Biologic Drug Treatment Consumption (2017-2022)
-
10.5.4 Argentina Neutropenia Biologic Drug Treatment Consumption (2017-2022)
-
10.5.5 Venezuela Neutropenia Biologic Drug Treatment Consumption (2017-2022)
-
10.5.6 Peru Neutropenia Biologic Drug Treatment Consumption (2017-2022)
-
10.5.7 Puerto Rico Neutropenia Biologic Drug Treatment Consumption (2017-2022)
-
10.5.8 Ecuador Neutropenia Biologic Drug Treatment Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Neutropenia Biologic Drug Treatment Consumption (2017-2022)
-
10.6.2 Kuwait Neutropenia Biologic Drug Treatment Consumption (2017-2022)
-
10.6.3 Oman Neutropenia Biologic Drug Treatment Consumption (2017-2022)
-
10.6.4 Qatar Neutropenia Biologic Drug Treatment Consumption (2017-2022)
-
10.6.5 Saudi Arabia Neutropenia Biologic Drug Treatment Consumption (2017-2022)
-
10.6.6 United Arab Emirates Neutropenia Biologic Drug Treatment Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Neutropenia Biologic Drug Treatment Consumption (2017-2022)
-
10.7.2 South Africa Neutropenia Biologic Drug Treatment Consumption (2017-2022)
-
10.7.3 Egypt Neutropenia Biologic Drug Treatment Consumption (2017-2022)
-
10.7.4 Algeria Neutropenia Biologic Drug Treatment Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Neutropenia Biologic Drug Treatment Consumption (2017-2022)
-
10.8.2 New Zealand Neutropenia Biologic Drug Treatment Consumption (2017-2022)
11 Global Neutropenia Biologic Drug Treatment Competitive Analysis
-
11.1 Myelo Therapeutics GmbH
-
11.1.1 Myelo Therapeutics GmbH Company Details
-
11.1.2 Myelo Therapeutics GmbH Neutropenia Biologic Drug Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Myelo Therapeutics GmbH Neutropenia Biologic Drug Treatment Main Business and Markets Served
-
11.1.4 Myelo Therapeutics GmbH Neutropenia Biologic Drug Treatment Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Dong-A ST CO Ltd
-
11.2.1 Dong-A ST CO Ltd Company Details
-
11.2.2 Dong-A ST CO Ltd Neutropenia Biologic Drug Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Dong-A ST CO Ltd Neutropenia Biologic Drug Treatment Main Business and Markets Served
-
11.2.4 Dong-A ST CO Ltd Neutropenia Biologic Drug Treatment Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 CVS Health
-
11.3.1 CVS Health Company Details
-
11.3.2 CVS Health Neutropenia Biologic Drug Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 CVS Health Neutropenia Biologic Drug Treatment Main Business and Markets Served
-
11.3.4 CVS Health Neutropenia Biologic Drug Treatment Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Amgen
-
11.4.1 Amgen Company Details
-
11.4.2 Amgen Neutropenia Biologic Drug Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Amgen Neutropenia Biologic Drug Treatment Main Business and Markets Served
-
11.4.4 Amgen Neutropenia Biologic Drug Treatment Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Baxter International
-
11.5.1 Baxter International Company Details
-
11.5.2 Baxter International Neutropenia Biologic Drug Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Baxter International Neutropenia Biologic Drug Treatment Main Business and Markets Served
-
11.5.4 Baxter International Neutropenia Biologic Drug Treatment Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Enzychem Lifesciences Corporation
-
11.6.1 Enzychem Lifesciences Corporation Company Details
-
11.6.2 Enzychem Lifesciences Corporation Neutropenia Biologic Drug Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Enzychem Lifesciences Corporation Neutropenia Biologic Drug Treatment Main Business and Markets Served
-
11.6.4 Enzychem Lifesciences Corporation Neutropenia Biologic Drug Treatment Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Kyowa Kirin
-
11.7.1 Kyowa Kirin Company Details
-
11.7.2 Kyowa Kirin Neutropenia Biologic Drug Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Kyowa Kirin Neutropenia Biologic Drug Treatment Main Business and Markets Served
-
11.7.4 Kyowa Kirin Neutropenia Biologic Drug Treatment Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Cellerant Therapeutics
-
11.8.1 Cellerant Therapeutics Company Details
-
11.8.2 Cellerant Therapeutics Neutropenia Biologic Drug Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Cellerant Therapeutics Neutropenia Biologic Drug Treatment Main Business and Markets Served
-
11.8.4 Cellerant Therapeutics Neutropenia Biologic Drug Treatment Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Partner Therapeutics
-
11.9.1 Partner Therapeutics Company Details
-
11.9.2 Partner Therapeutics Neutropenia Biologic Drug Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Partner Therapeutics Neutropenia Biologic Drug Treatment Main Business and Markets Served
-
11.9.4 Partner Therapeutics Neutropenia Biologic Drug Treatment Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Pfizer
-
11.10.1 Pfizer Company Details
-
11.10.2 Pfizer Neutropenia Biologic Drug Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Pfizer Neutropenia Biologic Drug Treatment Main Business and Markets Served
-
11.10.4 Pfizer Neutropenia Biologic Drug Treatment Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Novartis
-
11.11.1 Novartis Company Details
-
11.11.2 Novartis Neutropenia Biologic Drug Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Novartis Neutropenia Biologic Drug Treatment Main Business and Markets Served
-
11.11.4 Novartis Neutropenia Biologic Drug Treatment Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 Teva Pharmaceutical Industries Ltd
-
11.12.1 Teva Pharmaceutical Industries Ltd Company Details
-
11.12.2 Teva Pharmaceutical Industries Ltd Neutropenia Biologic Drug Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 Teva Pharmaceutical Industries Ltd Neutropenia Biologic Drug Treatment Main Business and Markets Served
-
11.12.4 Teva Pharmaceutical Industries Ltd Neutropenia Biologic Drug Treatment Product Portfolio
-
11.12.5 Recent Research and Development Strategies
-
11.13 Sanofi
-
11.13.1 Sanofi Company Details
-
11.13.2 Sanofi Neutropenia Biologic Drug Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
11.13.3 Sanofi Neutropenia Biologic Drug Treatment Main Business and Markets Served
-
11.13.4 Sanofi Neutropenia Biologic Drug Treatment Product Portfolio
-
11.13.5 Recent Research and Development Strategies
12 Global Neutropenia Biologic Drug Treatment Market Outlook by Types and Applications to 2028
-
12.1 Global Neutropenia Biologic Drug Treatment Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Filgrastim Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Pegfilgrastim Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global Lenograstim Consumption Forecast and Growth Rate (2022-2028)
-
12.1.4 Global Lipegfilgrastim Consumption Forecast and Growth Rate (2022-2028)
-
12.1.5 Global Sargramostim Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Neutropenia Biologic Drug Treatment Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Neutropenia Biologic Drug Treatment Market Analysis and Outlook to 2028
-
13.1 Global Neutropenia Biologic Drug Treatment Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Neutropenia Biologic Drug Treatment Consumption Forecast (2022-2028)
-
13.2.2 Canada Neutropenia Biologic Drug Treatment Consumption Forecast (2022-2028)
-
13.2.3 Mexico Neutropenia Biologic Drug Treatment Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Neutropenia Biologic Drug Treatment Consumption Forecast (2022-2028)
-
13.3.2 UK Neutropenia Biologic Drug Treatment Consumption Forecast (2022-2028)
-
13.3.3 Spain Neutropenia Biologic Drug Treatment Consumption Forecast (2022-2028)
-
13.3.4 Belgium Neutropenia Biologic Drug Treatment Consumption Forecast (2022-2028)
-
13.3.5 France Neutropenia Biologic Drug Treatment Consumption Forecast (2022-2028)
-
13.3.6 Italy Neutropenia Biologic Drug Treatment Consumption Forecast (2022-2028)
-
13.3.7 Denmark Neutropenia Biologic Drug Treatment Consumption Forecast (2022-2028)
-
13.3.8 Finland Neutropenia Biologic Drug Treatment Consumption Forecast (2022-2028)
-
13.3.9 Norway Neutropenia Biologic Drug Treatment Consumption Forecast (2022-2028)
-
13.3.10 Sweden Neutropenia Biologic Drug Treatment Consumption Forecast (2022-2028)
-
13.3.11 Poland Neutropenia Biologic Drug Treatment Consumption Forecast (2022-2028)
-
13.3.12 Russia Neutropenia Biologic Drug Treatment Consumption Forecast (2022-2028)
-
13.3.13 Turkey Neutropenia Biologic Drug Treatment Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Neutropenia Biologic Drug Treatment Consumption Forecast (2022-2028)
-
13.4.2 Japan Neutropenia Biologic Drug Treatment Consumption Forecast (2022-2028)
-
13.4.3 India Neutropenia Biologic Drug Treatment Consumption Forecast (2022-2028)
-
13.4.4 South Korea Neutropenia Biologic Drug Treatment Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Neutropenia Biologic Drug Treatment Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Neutropenia Biologic Drug Treatment Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Neutropenia Biologic Drug Treatment Consumption Forecast (2022-2028)
-
13.4.8 Thailand Neutropenia Biologic Drug Treatment Consumption Forecast (2022-2028)
-
13.4.9 Singapore Neutropenia Biologic Drug Treatment Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Neutropenia Biologic Drug Treatment Consumption Forecast (2022-2028)
-
13.4.11 Philippines Neutropenia Biologic Drug Treatment Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Neutropenia Biologic Drug Treatment Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Neutropenia Biologic Drug Treatment Consumption Forecast (2022-2028)
-
13.5.2 Colombia Neutropenia Biologic Drug Treatment Consumption Forecast (2022-2028)
-
13.5.3 Chile Neutropenia Biologic Drug Treatment Consumption Forecast (2022-2028)
-
13.5.4 Argentina Neutropenia Biologic Drug Treatment Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Neutropenia Biologic Drug Treatment Consumption Forecast (2022-2028)
-
13.5.6 Peru Neutropenia Biologic Drug Treatment Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Neutropenia Biologic Drug Treatment Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Neutropenia Biologic Drug Treatment Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Neutropenia Biologic Drug Treatment Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Neutropenia Biologic Drug Treatment Consumption Forecast (2022-2028)
-
13.6.3 Oman Neutropenia Biologic Drug Treatment Consumption Forecast (2022-2028)
-
13.6.4 Qatar Neutropenia Biologic Drug Treatment Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Neutropenia Biologic Drug Treatment Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Neutropenia Biologic Drug Treatment Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Neutropenia Biologic Drug Treatment Consumption Forecast (2022-2028)
-
13.7.2 South Africa Neutropenia Biologic Drug Treatment Consumption Forecast (2022-2028)
-
13.7.3 Egypt Neutropenia Biologic Drug Treatment Consumption Forecast (2022-2028)
-
13.7.4 Algeria Neutropenia Biologic Drug Treatment Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Neutropenia Biologic Drug Treatment Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Neutropenia Biologic Drug Treatment Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Neutropenia Biologic Drug Treatment
-
Figure of Neutropenia Biologic Drug Treatment Picture
-
Table Global Neutropenia Biologic Drug Treatment Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Neutropenia Biologic Drug Treatment Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Filgrastim Consumption and Growth Rate (2017-2022)
-
Figure Global Pegfilgrastim Consumption and Growth Rate (2017-2022)
-
Figure Global Lenograstim Consumption and Growth Rate (2017-2022)
-
Figure Global Lipegfilgrastim Consumption and Growth Rate (2017-2022)
-
Figure Global Sargramostim Consumption and Growth Rate (2017-2022)
-
Figure Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Online Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Neutropenia Biologic Drug Treatment Consumption by Country (2017-2022)
-
Table North America Neutropenia Biologic Drug Treatment Consumption by Country (2017-2022)
-
Figure United States Neutropenia Biologic Drug Treatment Consumption and Growth Rate (2017-2022)
-
Figure Canada Neutropenia Biologic Drug Treatment Consumption and Growth Rate (2017-2022)
-
Figure Mexico Neutropenia Biologic Drug Treatment Consumption and Growth Rate (2017-2022)
-
Table Europe Neutropenia Biologic Drug Treatment Consumption by Country (2017-2022)
-
Figure Germany Neutropenia Biologic Drug Treatment Consumption and Growth Rate (2017-2022)
-
Figure UK Neutropenia Biologic Drug Treatment Consumption and Growth Rate (2017-2022)
-
Figure Spain Neutropenia Biologic Drug Treatment Consumption and Growth Rate (2017-2022)
-
Figure Belgium Neutropenia Biologic Drug Treatment Consumption and Growth Rate (2017-2022)
-
Figure France Neutropenia Biologic Drug Treatment Consumption and Growth Rate (2017-2022)
-
Figure Italy Neutropenia Biologic Drug Treatment Consumption and Growth Rate (2017-2022)
-
Figure Denmark Neutropenia Biologic Drug Treatment Consumption and Growth Rate (2017-2022)
-
Figure Finland Neutropenia Biologic Drug Treatment Consumption and Growth Rate (2017-2022)
-
Figure Norway Neutropenia Biologic Drug Treatment Consumption and Growth Rate (2017-2022)
-
Figure Sweden Neutropenia Biologic Drug Treatment Consumption and Growth Rate (2017-2022)
-
Figure Poland Neutropenia Biologic Drug Treatment Consumption and Growth Rate (2017-2022)
-
Figure Russia Neutropenia Biologic Drug Treatment Consumption and Growth Rate (2017-2022)
-
Figure Turkey Neutropenia Biologic Drug Treatment Consumption and Growth Rate (2017-2022)
-
Table APAC Neutropenia Biologic Drug Treatment Consumption by Country (2017-2022)
-
Figure China Neutropenia Biologic Drug Treatment Consumption and Growth Rate (2017-2022)
-
Figure Japan Neutropenia Biologic Drug Treatment Consumption and Growth Rate (2017-2022)
-
Figure India Neutropenia Biologic Drug Treatment Consumption and Growth Rate (2017-2022)
-
Figure South Korea Neutropenia Biologic Drug Treatment Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Neutropenia Biologic Drug Treatment Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Neutropenia Biologic Drug Treatment Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Neutropenia Biologic Drug Treatment Consumption and Growth Rate (2017-2022)
-
Figure Thailand Neutropenia Biologic Drug Treatment Consumption and Growth Rate (2017-2022)
-
Figure Singapore Neutropenia Biologic Drug Treatment Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Neutropenia Biologic Drug Treatment Consumption and Growth Rate (2017-2022)
-
Figure Philippines Neutropenia Biologic Drug Treatment Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Neutropenia Biologic Drug Treatment Consumption and Growth Rate (2017-2022)
-
Table South America Neutropenia Biologic Drug Treatment Consumption by Country (2017-2022)
-
Figure Brazil Neutropenia Biologic Drug Treatment Consumption and Growth Rate (2017-2022)
-
Figure Colombia Neutropenia Biologic Drug Treatment Consumption and Growth Rate (2017-2022)
-
Figure Chile Neutropenia Biologic Drug Treatment Consumption and Growth Rate (2017-2022)
-
Figure Argentina Neutropenia Biologic Drug Treatment Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Neutropenia Biologic Drug Treatment Consumption and Growth Rate (2017-2022)
-
Figure Peru Neutropenia Biologic Drug Treatment Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Neutropenia Biologic Drug Treatment Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Neutropenia Biologic Drug Treatment Consumption and Growth Rate (2017-2022)
-
Table GCC Neutropenia Biologic Drug Treatment Consumption by Country (2017-2022)
-
Figure Bahrain Neutropenia Biologic Drug Treatment Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Neutropenia Biologic Drug Treatment Consumption and Growth Rate (2017-2022)
-
Figure Oman Neutropenia Biologic Drug Treatment Consumption and Growth Rate (2017-2022)
-
Figure Qatar Neutropenia Biologic Drug Treatment Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Neutropenia Biologic Drug Treatment Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Neutropenia Biologic Drug Treatment Consumption and Growth Rate (2017-2022)
-
Table Africa Neutropenia Biologic Drug Treatment Consumption by Country (2017-2022)
-
Figure Nigeria Neutropenia Biologic Drug Treatment Consumption and Growth Rate (2017-2022)
-
Figure South Africa Neutropenia Biologic Drug Treatment Consumption and Growth Rate (2017-2022)
-
Figure Egypt Neutropenia Biologic Drug Treatment Consumption and Growth Rate (2017-2022)
-
Figure Algeria Neutropenia Biologic Drug Treatment Consumption and Growth Rate (2017-2022)
-
Table Oceania Neutropenia Biologic Drug Treatment Consumption by Country (2017-2022)
-
Figure Australia Neutropenia Biologic Drug Treatment Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Neutropenia Biologic Drug Treatment Consumption and Growth Rate (2017-2022)
-
Table Myelo Therapeutics GmbH Company Details
-
Table Myelo Therapeutics GmbH Neutropenia Biologic Drug Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Myelo Therapeutics GmbH Neutropenia Biologic Drug Treatment Main Business and Markets Served
-
Table Myelo Therapeutics GmbH Neutropenia Biologic Drug Treatment Product Portfolio
-
Table Dong-A ST CO Ltd Company Details
-
Table Dong-A ST CO Ltd Neutropenia Biologic Drug Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Dong-A ST CO Ltd Neutropenia Biologic Drug Treatment Main Business and Markets Served
-
Table Dong-A ST CO Ltd Neutropenia Biologic Drug Treatment Product Portfolio
-
Table CVS Health Company Details
-
Table CVS Health Neutropenia Biologic Drug Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table CVS Health Neutropenia Biologic Drug Treatment Main Business and Markets Served
-
Table CVS Health Neutropenia Biologic Drug Treatment Product Portfolio
-
Table Amgen Company Details
-
Table Amgen Neutropenia Biologic Drug Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Neutropenia Biologic Drug Treatment Main Business and Markets Served
-
Table Amgen Neutropenia Biologic Drug Treatment Product Portfolio
-
Table Baxter International Company Details
-
Table Baxter International Neutropenia Biologic Drug Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Baxter International Neutropenia Biologic Drug Treatment Main Business and Markets Served
-
Table Baxter International Neutropenia Biologic Drug Treatment Product Portfolio
-
Table Enzychem Lifesciences Corporation Company Details
-
Table Enzychem Lifesciences Corporation Neutropenia Biologic Drug Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Enzychem Lifesciences Corporation Neutropenia Biologic Drug Treatment Main Business and Markets Served
-
Table Enzychem Lifesciences Corporation Neutropenia Biologic Drug Treatment Product Portfolio
-
Table Kyowa Kirin Company Details
-
Table Kyowa Kirin Neutropenia Biologic Drug Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Kyowa Kirin Neutropenia Biologic Drug Treatment Main Business and Markets Served
-
Table Kyowa Kirin Neutropenia Biologic Drug Treatment Product Portfolio
-
Table Cellerant Therapeutics Company Details
-
Table Cellerant Therapeutics Neutropenia Biologic Drug Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cellerant Therapeutics Neutropenia Biologic Drug Treatment Main Business and Markets Served
-
Table Cellerant Therapeutics Neutropenia Biologic Drug Treatment Product Portfolio
-
Table Partner Therapeutics Company Details
-
Table Partner Therapeutics Neutropenia Biologic Drug Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Partner Therapeutics Neutropenia Biologic Drug Treatment Main Business and Markets Served
-
Table Partner Therapeutics Neutropenia Biologic Drug Treatment Product Portfolio
-
Table Pfizer Company Details
-
Table Pfizer Neutropenia Biologic Drug Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Neutropenia Biologic Drug Treatment Main Business and Markets Served
-
Table Pfizer Neutropenia Biologic Drug Treatment Product Portfolio
-
Table Novartis Company Details
-
Table Novartis Neutropenia Biologic Drug Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Neutropenia Biologic Drug Treatment Main Business and Markets Served
-
Table Novartis Neutropenia Biologic Drug Treatment Product Portfolio
-
Table Teva Pharmaceutical Industries Ltd Company Details
-
Table Teva Pharmaceutical Industries Ltd Neutropenia Biologic Drug Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Pharmaceutical Industries Ltd Neutropenia Biologic Drug Treatment Main Business and Markets Served
-
Table Teva Pharmaceutical Industries Ltd Neutropenia Biologic Drug Treatment Product Portfolio
-
Table Sanofi Company Details
-
Table Sanofi Neutropenia Biologic Drug Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Neutropenia Biologic Drug Treatment Main Business and Markets Served
-
Table Sanofi Neutropenia Biologic Drug Treatment Product Portfolio
-
Figure Global Filgrastim Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pegfilgrastim Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Lenograstim Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Lipegfilgrastim Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Sargramostim Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Neutropenia Biologic Drug Treatment Consumption Forecast by Country (2022-2028)
-
Table North America Neutropenia Biologic Drug Treatment Consumption Forecast by Country (2022-2028)
-
Figure United States Neutropenia Biologic Drug Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Neutropenia Biologic Drug Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Neutropenia Biologic Drug Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Neutropenia Biologic Drug Treatment Consumption Forecast by Country (2022-2028)
-
Figure Germany Neutropenia Biologic Drug Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Neutropenia Biologic Drug Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Neutropenia Biologic Drug Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Neutropenia Biologic Drug Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Neutropenia Biologic Drug Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Neutropenia Biologic Drug Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Neutropenia Biologic Drug Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Neutropenia Biologic Drug Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Neutropenia Biologic Drug Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Neutropenia Biologic Drug Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Neutropenia Biologic Drug Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Neutropenia Biologic Drug Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Neutropenia Biologic Drug Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Neutropenia Biologic Drug Treatment Consumption Forecast by Country (2022-2028)
-
Figure China Neutropenia Biologic Drug Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Neutropenia Biologic Drug Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Neutropenia Biologic Drug Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Neutropenia Biologic Drug Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Neutropenia Biologic Drug Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Neutropenia Biologic Drug Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Neutropenia Biologic Drug Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Neutropenia Biologic Drug Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Neutropenia Biologic Drug Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Neutropenia Biologic Drug Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Neutropenia Biologic Drug Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Neutropenia Biologic Drug Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Neutropenia Biologic Drug Treatment Consumption Forecast by Country (2022-2028)
-
Figure Brazil Neutropenia Biologic Drug Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Neutropenia Biologic Drug Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Neutropenia Biologic Drug Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Neutropenia Biologic Drug Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Neutropenia Biologic Drug Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Neutropenia Biologic Drug Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Neutropenia Biologic Drug Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Neutropenia Biologic Drug Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Neutropenia Biologic Drug Treatment Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Neutropenia Biologic Drug Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Neutropenia Biologic Drug Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Neutropenia Biologic Drug Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Neutropenia Biologic Drug Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Neutropenia Biologic Drug Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Neutropenia Biologic Drug Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Neutropenia Biologic Drug Treatment Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Neutropenia Biologic Drug Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Neutropenia Biologic Drug Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Neutropenia Biologic Drug Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Neutropenia Biologic Drug Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Neutropenia Biologic Drug Treatment Consumption Forecast by Country (2022-2028)
-
Figure Australia Neutropenia Biologic Drug Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Neutropenia Biologic Drug Treatment Consumption Forecast and Growth Rate (2022-2028)
-
